Safety of resuming tumour necrosis factor inhibitors in patients who developed tuberculosis as a complication of previous TNF inhibitors.

@article{Kim2014SafetyOR,
  title={Safety of resuming tumour necrosis factor inhibitors in patients who developed tuberculosis as a complication of previous TNF inhibitors.},
  author={You Jae Kim and Yong-Gil Kim and Tae Sun Shim and Bon San Koo and Seokchan Hong and Chang-Keun Lee and Bin Yoo},
  journal={Rheumatology},
  year={2014},
  volume={53 8},
  pages={1477-81}
}
OBJECTIVES There is no consensus on whether restarting TNF inhibitors (TNFis) after treatment of an active tuberculosis (TB) infection caused by previous TNFi exposure is safe. In this study we sought to determine the safety of resuming TNFis in patients following TB treatment. METHODS The medical records of all patients (n = 683) that received TNFi… CONTINUE READING